ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort

ClinicalTrials.gov ID: NCT06492174

Public ClinicalTrials.gov record NCT06492174. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

AGENT IDE: A Prospective, Randomized (2:1), Multicenter Trial to Assess the Safety and Effectiveness of the AgentTM Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR)

Study identification

NCT ID
NCT06492174
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Boston Scientific Corporation
Industry
Enrollment
20 participants

Conditions and interventions

Interventions

  • AGENT DCB 40 mm Device

Device

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 6, 2024
Primary completion
Dec 18, 2025
Completion
Nov 30, 2027
Last update posted
Apr 26, 2026

2024 – 2027

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Carondelet Medical Group St. Mary's Hospital Tucson Arizona 85745
Cedars Sinai Medical Center Los Angeles California 90048
Emory University Hospital Atlanta Georgia 30322
Henry Ford Hospital Detroit Michigan 48202
Columbia University Medical Center New York New York 10032
St. Francis Hospital Roslyn New York 11576
Lindner Center for Research and Education at Christ Hospital Cincinnati Ohio 45219
UPMC Pinnacle Health Wormleysburg Pennsylvania 17053
Rhode Island Hospital Providence Rhode Island 02903
Centennial Medical Center Nashville Tennessee 37203
Baylor Heart and Vascular Hospital Dallas Texas 75226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06492174, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06492174 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →